| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 58 | 74 | 78 | 69 | 62 | 31 | 0 |
| Expenses | 50 | 62 | 74 | 56 | 51 | 38 | 0 |
| EBITDA | 8 | 12 | 5 | 13 | 11 | -6 | 0 |
| Operating Profit % | 13 % | 16 % | 5 % | 18 % | 18 % | -22 % | 0 % |
| Depreciation | 4 | 4 | 4 | 5 | 6 | 4 | 0 |
| Interest | 7 | 8 | 6 | 6 | 6 | 3 | 0 |
| Profit Before Tax | -4 | 1 | -6 | 2 | 0 | -26 | 0 |
| Tax | 0 | 1 | -1 | 0 | -1 | 0 | 0 |
| Net Profit | -4 | 0 | -6 | 2 | 1 | -26 | 0 |
| EPS in ₹ | -1.62 | 0.02 | -2.21 | 0.81 | 0.34 | -10.39 | 0.00 |
Cian Healthcare
Cian Healthcare
5.08
+0.09
(1.80%)
Market Cap
₹12.73 Cr
PE Ratio
-0.48
Volume
10,000.00
Day High - Low
₹5.08 - ₹5.08
52W High-Low
₹7.66 - ₹2.97
There are 6 new updates from the company23 hours ago
View
Key Fundamentals
Market Cap
12.73 Cr
EPS
-10.39
PB Ratio
0.39
Book Value
12.95
EBITDA
-6.40
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-80.28
Debt to Equity
1.22
Actual
Company News
View All News
Cian Healthcare Limited announces deemed resignation of Managing Director, Independent Director, Company Secretary, and CFO following NCLT approval of resolution plan on December 18, 2025.
Cian Healthcare Limited shareholders approved FY25 financial statements and appointed KNG C and Associate LLP as secretarial auditors for 5 years during 22nd AGM held on December 17, 2025.
Cian Healthcare Reports Audited Consolidated Results with Disclaimer Opinion Due to CIRP Constraints
Nov 18, 2025
Nov 18, 2025Cian Healthcare Limited released audited consolidated financial statements for the year ended March 31, 2025, but received a disclaimer of opinion from auditors due to insufficient evidence arising from ongoing Corporate Insolvency Resolution Process (CIRP) affecting both the company and its subsidiary Dr. Smiths Biotech Private Limited. The auditors cited extensive limitations including incomplete records, unverified inventory valuations, missing documentation for assets and liabilities, and inability to assess going concern status, preventing them from forming an audit opinion on the consolidated financial statements.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,737.00 | #1 4,16,764.48 | 40.16 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 41.99 | |
6,496.50 | 1,72,461.66 | 69.16 | 9,712.00 | 18.67 | 2,191 | 35.10 | 54.95 | |
3,834.30 | 1,29,770.14 | 60.40 | 11,539.40 | 6.99 | 1,911 | 30.46 | 64.03 | |
1,496.30 | 1,20,864.24 | 22.30 | 28,409.50 | 7.12 | 5,291 | 3.71 | 43.36 | |
1,265.80 | 1,05,645.41 | 18.66 | 33,741.20 | 16.73 | 5,725 | -0.38 | 50.22 | |
2,107.00 | 96,238.18 | 22.21 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.72 | |
917.80 | 92,352.16 | #1 18.57 | 23,511.00 | 18.55 | 4,615 | 34.60 | 41.66 | |
2,193.30 | 90,530.32 | 51.90 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 47.28 | |
1,211.40 | 70,358.31 | 20.66 | 32,345.60 | 9.43 | 3,484 | 3.81 | 55.09 | |
5,566.00 | 66,549.88 | 27.75 | 13,458.30 | 3.70 | 2,216 | 10.98 | 44.89 |
Growth Rate
Revenue Growth
-49.92 %
Net Income Growth
-3,350.00 %
Cash Flow Change
76.45 %
ROE
-5,636.55 %
ROCE
-1,002.76 %
EBITDA Margin (Avg.)
-213.85 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 157 | 157 | 166 | 161 | 161 | 156 |
| Fixed Assets | 39 | 37 | 50 | 45 | 39 | 35 |
| Current Assets | 54 | 63 | 79 | 74 | 72 | 71 |
| Capital Work in Progress | 25 | 26 | 13 | 14 | 15 | 15 |
| Investments | 5 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 87 | 95 | 103 | 102 | 107 | 106 |
| Total Liabilities | 157 | 157 | 166 | 161 | 161 | 156 |
| Current Liabilities | 49 | 58 | 70 | 65 | 66 | 115 |
| Non Current Liabilities | 50 | 41 | 41 | 38 | 37 | 9 |
| Total Equity | 58 | 58 | 56 | 58 | 58 | 32 |
| Reserve & Surplus | 35 | 35 | 31 | 33 | 33 | 7 |
| Share Capital | 23 | 23 | 25 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -1 | -1 | 0 | -0 | 17 |
| Investing Activities | -27 | 3 | 1 | 3 | -2 | -0 |
| Operating Activities | -7 | 6 | 9 | 5 | 12 | 21 |
| Financing Activities | 36 | -10 | -11 | -7 | -10 | -4 |
Share Holding
| % Holding | Mar 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Mar 2025 | Sept 2025 |
| Promoter | 70.89 % | 70.89 % | 0.00 % | 66.26 % | 66.26 % | 66.26 % | 51.85 % | 49.62 % | 27.10 % | 27.10 % | 27.10 % | 27.10 % | 27.10 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.79 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 17.48 % | 18.09 % | 0.00 % | 23.77 % | 23.95 % | 24.00 % | 41.88 % | 41.08 % | 55.78 % | 56.59 % | 59.23 % | 63.56 % | 63.77 % |
| Others | 11.62 % | 11.02 % | 100.00 % | 9.97 % | 9.80 % | 8.95 % | 6.27 % | 9.30 % | 17.12 % | 16.31 % | 13.67 % | 9.34 % | 9.12 % |
| No of Share Holders | 361 | 385 | 396 | 392 | 424 | 418 | 454 | 672 | 880 | 831 | 1,088 | 1,501 | 1,662 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Oct 2024 |  Annual General Meeting | NA | 08 Oct 2024 | 5.46 | 4.96 |
| 17 Dec 2025 | Annual General Meeting | NA | 17 Dec 2025 | 6.19 | 5.10 |
Announcements
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Resignation of Director22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Resignation of Managing Director23 hours ago
23 hours agoAnnouncement under Regulation 30 (LODR)-Change in Management23 hours ago
23 hours agoBoard Meeting Outcome for Outcome Of The First Meeting (CIAN/RPIC/2025-26/01) Of The Resolution Plan Implementation Committee (Implementation Committee) Held On December 24 2025.23 hours ago
23 hours agoConstitution Of The Resolution Plan Implementation Committee Of Cian Healthcare Limited Pursuant To The Approval Of The Resolution Plan By The Honble NCLT.4 days ago
4 days agoCorporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Change in Management7 days ago
7 days agoSummary Of Proceedings Of The 22Nd Annual General Meeting Of The Company Held On December 17 2025.7 days ago
7 days agoShareholder Meeting / Postal Ballot-Scrutinizers Report7 days ago
7 days agoShareholder Meeting / Postal Ballot-Outcome of AGM7 days ago
7 days agoClarification Regarding Extension Of Annual General Meeting (AGM) Of Cian Healthcare Limited (Company).Nov 29, 2025
Nov 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 27, 2025
Nov 27, 2025Corrigendum To The Notice Of 22Nd Annual General Meeting ("AGM") Of The Company Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conferencing/Other Audio-Visual Means.Nov 25, 2025
Nov 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 25, 2025
Nov 25, 2025Reg. 34 (1) Annual Report.Nov 24, 2025
Nov 24, 2025Notice Of The 22Nd (Twenty-Second) Annual General Meeting Of The Members Of Cian Healthcare Limited Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conference /Other Audio-Visual Means ("VC / OAVM").Nov 24, 2025
Nov 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 22, 2025
Nov 22, 2025Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 By Cian Healthcare Limited
(Company)Nov 21, 2025
Nov 21, 2025Results - Consolidated Financial Results As At 31-03-2025.Nov 18, 2025
Nov 18, 2025Un-Audited Standalone Financial Results For The Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by TribunalNov 06, 2025
Nov 06, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsOct 17, 2025
Oct 17, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Sep 18, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Sep 11, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsSep 10, 2025
Sep 10, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Sep 03, 2025
Sep 03, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 22, 2025
Aug 22, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 06, 2025
Aug 06, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 05, 2025
Aug 05, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 01, 2025
Jul 01, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJun 24, 2025
Jun 24, 2025Financial Results For Year Ended 31/03/2025Jun 19, 2025
Jun 19, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jun 05, 2025
Jun 05, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 30, 2025
May 30, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMay 28, 2025
May 28, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)May 24, 2025
May 24, 2025Initiation Of CIRP Against Dr. Smiths Biotech Private Limited (CIN: U24246PN2015PTC154818) A Wholly Owned Subsidiary Of The CompanyMay 24, 2025
May 24, 2025Corporate Insolvency Resolution Process (CIRP)-Filing of Resolution plan with TribunalMay 24, 2025
May 24, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 09, 2025
May 09, 2025Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 And SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 Dated August 10 2021.Apr 28, 2025
Apr 28, 2025Clarification Letter For Technical Error For Filing Form INC-22 With Respect To Change In Registered Office Of The Company With The MCA Portal.Apr 19, 2025
Apr 19, 2025Technical Indicators
RSI(14)
Neutral 31.28
ATR(14)
Less Volatile 0.12
STOCH(9,6)
Neutral 20.76
STOCH RSI(14)
Neutral 53.54
MACD(12,26)
Bearish -0.06
ADX(14)
Strong Trend 48.84
UO(9)
Bearish 36.97
ROC(12)
Downtrend And Accelerating -11.34
WillR(14)
Neutral -67.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
